bromodeoxyuridine has been researched along with Malignant Melanoma in 110 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 70 (63.64) | 18.7374 |
1990's | 27 (24.55) | 18.2507 |
2000's | 6 (5.45) | 29.6817 |
2010's | 6 (5.45) | 24.3611 |
2020's | 1 (0.91) | 2.80 |
Authors | Studies |
---|---|
Braumann, C; Buchholz, M; Gambichler, T; Harnischfeger, F; Majchrzak-Stiller, B; Müller, T; Skrygan, M | 1 |
Bauer, AT; Doerflinger, Y; Fischer-Colbrie, R; Goerdt, S; Huck, V; Peitsch, WK; Schneider, SW; Utikal, J | 1 |
Costa, VM; Diniz, C; Fresco, P; Soares, AS | 1 |
Kato, S; Kimura, M; Miwa, N | 1 |
Rieber, M; Rieber, MS | 2 |
Bezerra, DP; Câmara, CA; Cavalcanti, BC; Costa-Lotufo, LV; Lima, MA; Magalhães, HI; Moraes, MO; Pessoa, C; Rao, VS; Silveira, ER | 1 |
Denton, CL; Gustafson, DL | 1 |
Chen, L; Gao, X; Huang, CH; Huang, SL; Lu, Y; Punchard, NA; Sun, ZG; Wang, AY; Zheng, SZ | 1 |
Fletcher, JA; Giobbie-Hurder, A; Hodi, FS; Wu, X; Zhu, M | 1 |
Laing, JH; Martindale, CA; Wilson, GD | 1 |
Bhawe, KM; Blake, RA; Clary, DO; Flanagan, PM | 1 |
Barone, C; Beraldi, R; Cassano, A; Garaci, E; Landriscina, M; Mattei, E; Mearelli, C; Pittoggi, C; Quirino, M; Sciamanna, I; Serafino, A; Sinibaldi-Vallebona, P; Spadafora, C | 1 |
Alves, PR | 1 |
Brunson, KW; Giotta, GJ; Lotan, R | 1 |
Horn, D; Petruska, J | 2 |
Collins, JM; Jenkins, J; Kinsella, TJ; Kornblith, P; Mitchell, JB; Myers, CE; Rowland, J; Russo, A; Schwade, J; Speyer, J | 1 |
Gratzner, H; Hsu, SM; Kinsella, T; Mitchell, JB; Morstyn, G; Russo, A | 1 |
Gratzner, H; Hsu, SM; Kinsella, T; Mitchell, J; Morstyn, G; Russo, A | 1 |
Lira, R; Rieber, M; Rieber, MS; Urbina, C | 1 |
Castillo, MA; Rieber, M | 1 |
Sugita, Y; Takeuchi, T | 1 |
Fanelli, C; Morpurgo, G; Passi, S; Porro, MN | 1 |
Kinoshita, Y; Makita, A; Takeuchi, T | 1 |
Gyi, KK; Wrathall, JR | 1 |
Becher, R; Bregula, U; Gibas, Z; Limon, J; Rochowska, M; Sandberg, AA | 1 |
Ashman, CR; Davidson, RL; Reddy, GP | 1 |
Calvelli, TA; Silagi, S | 1 |
Bick, MD; Cullen, BR; Fasy, TM; Luk, D | 1 |
Jonasson, J; Santesson, B; Ström, A | 1 |
Char, D; Kaleta-Michaels, S; Kroll, S | 1 |
Char, DH; Frigillana, H; Ghazvini, S; Kroll, S | 1 |
Baguley, BC; Finlay, GJ; Holdaway, KM; Marshall, ES; Matthews, JH; Shaw, JH | 1 |
Bodell, WJ; Dewey, WC; Gardiner, K; Latz, DL; Thompson, LL; Trinh, MM; Zhu, Y | 1 |
Elder, DE; Greenstein, D; Györfi, T; Herlyn, M; Juhasz, I; Shih, IM; Valyi-Nagy, I | 1 |
Heimpel, S; Hiller, KH; Hoehn, H; Köhler, J; Poot, M; Schuster, A | 1 |
Hillebrandt, S; Streffer, C; Zölzer, F | 1 |
Char, DH; Ghazvini, S; Kishore, K; Kroll, S; Selle, J | 1 |
De Jong, PT; Hagemeijer, A; Kan-Mitchell, J; Luider, TM; Luyten, GP; Mooy, CM; Naus, NC; Van Drunen, E; Vuzevski, V | 1 |
Miele, ME; Rieber, M; Strasberg Rieber, M; Welch, DR | 1 |
Das, PK; Lamers, WH; Le Poole, IC; Troost, D; Van den Wijngaard, RM; Verkruisen, RP; Westerhof, W | 1 |
Gomez, LA; Rieber, M; Strasberg Rieber, M | 1 |
Hu, DN; Roberts, JE | 1 |
Imamura, S; Masaki, T; Ninomiya, H; Ohtani, T; Okazawa, M | 1 |
Char, DH; Elbakri, HR; Frigillana, H; Ghazvini, S; Kroll, S; Lattman, J; O'Brien, JM | 1 |
Ishikawa, K; Iwasaki, T; Kati, S; Lackner, AA; Masegi, T; Ohta, J; Sakai, H; Yanai, T; Yoshida, K | 1 |
Haapajärvi, T; Laiho, M; Pitkänen, K | 1 |
Bläuenstein, P; Böni, R; Dummer, R; Schubiger, PA; Steinert, HC; von Schulthess, GK | 1 |
Streffer, C; Zölzer, F | 1 |
Davidson, RL; Reff, ME | 1 |
Acs, G; Christman, JK; Newcomb, EW; Silagi, S; Silverstein, SC | 1 |
Davidson, RL; Horn, D | 3 |
Pawelek, JM | 1 |
Gericke, D | 1 |
Acs, G; Christman, J; Kyner, D; Newcomb, EW; Silagi, S; Silverstein, SC | 1 |
Newcomb, EW; Silagi, S; Silverstein, SC | 1 |
Munzenrider, JE | 1 |
Bick, MD; Devine, EA | 1 |
Anders, F; Kollinger, G; Schwab, M | 1 |
Davidson, RL; Kaufman, ER | 3 |
Banerjee, SP; Bosmann, HB; Evans, I; Kung, LS | 1 |
Silagi, S | 2 |
Balint, R; Newcomb, EW; Silagi, S; Wrathall, JR; Zeitz, L | 1 |
Bosmann, HB; Case, KR; DiStefano, P; Evans, I | 1 |
Balint, RF; Gauri, KK; Silagi, S | 1 |
Price, PM | 1 |
Fialkow, PJ; Glovanella, BC; Leibovitz, A; Morgan, AC; Mumford, DM; Santamaria, C; Stehlin, JS; Williams, LJ; Yim, SO | 1 |
Banks, J; Davidson, EA; Garlick, S; Kreider, JW; Sato, C | 1 |
Laing, JH; Rew, DA; Wilson, GD | 1 |
Menko, W; Pavel, S; Peters, K; Riley, PA; Smit, NP; Westerhof, W | 1 |
Irie, RF; Kern, DH; Kunitomo, K | 1 |
Bogdahn, U; Hoehn, H; Otto, F; Poot, M | 1 |
Feyles, V; Jerry, LM; McGarry, RC; Sikora, LK | 1 |
Dixon, WT; Feyles, V; Jerry, LM; McGarry, RC; Sikora, LK | 1 |
Bardenstein, DS; Char, DH; Kaleta-Michaels, S; Kroll, SM | 1 |
De Haan, JB; Kidson, SH | 1 |
Char, DH; Crawford, JB; Howes, EL; Kaleta-Michaels, S; Lovato, AA; Quivey, JM | 1 |
Char, DH; Kaleta, S; Kindy-Degnan, N; Ljung, BM; Swift, P | 1 |
Char, DH | 1 |
Abdel-Malek, ZA; Boissy, RE; Ferroni, EN; Nordlund, JJ; Swope, VB; Trinkle, LS | 1 |
Abdel-Malek, ZA; Nordlund, JJ; Swope, VB; Trinkle, LS | 1 |
deFazio, A; Hedley, DW; Leary, JA; Tattersall, MH | 1 |
Kaufman, ER | 1 |
Kawakubo, Y; Liao, SK; Singal, DP; Smith, JW; Wong, YH | 1 |
Ashman, CR; Davidson, RL; Kaufman, ER | 1 |
Albert, DM; Darling, TL; Reid, TW; Russell, P | 1 |
Lieber, MM; Sherr, CJ; Todaro, GJ | 1 |
Endo, H; Hu, F | 1 |
Hoshino, T | 1 |
Beju, D; Deharven, E; Silagi, S; Wrathall, J | 1 |
Newcomb, EW; Silagi, S; Weksler, ME | 1 |
Oikawa, A | 1 |
Bick, MD; Davidson, RL | 2 |
Hu, F; McNulty, WP; Pasztor, LM | 1 |
Essner, E; Oliver, C; Silagi, S; Wrathall, JR | 1 |
Zeidman, I | 1 |
Drake, TE; Epstein, WL; Fukuyama, K | 1 |
Bigley, R; Hu, F; Pasztor, LM; Stankova, L | 1 |
Beltz, B; Kreider, JW; Matheson, DW; Rosenthal, M | 1 |
Doores, L; Schulman, JD; Silagi, S; Wrathall, JR | 1 |
Bruce, SA; Silagi, S | 1 |
Hu, F; Pasztor, LM | 1 |
Glick, JL; Majumdar, A | 1 |
5 review(s) available for bromodeoxyuridine and Malignant Melanoma
Article | Year |
---|---|
Factors regulating growth and pigmentation of melanoma cells.
Topics: Animals; Bone Neoplasms; Bromodeoxyuridine; Catechol Oxidase; Cell Division; Cell Line; Cell Transformation, Neoplastic; Cricetinae; Cyclic AMP; Dihydroxyphenylalanine; Melanins; Melanocyte-Stimulating Hormones; Melanocytes; Melanoma; Mice; Neoplasms, Experimental; Oncogenic Viruses; Pigmentation; Tyrosine | 1976 |
Recent advances in radiotherapy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1977 |
Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells.
Topics: Animals; Antibody Formation; Antigens, Neoplasm; Bromodeoxyuridine; Catechol Oxidase; Cell Division; Cell Line; Cells, Cultured; DNA, Neoplasm; Kinetics; Melanins; Melanoma; Mice; Mice, Inbred C57BL; Models, Biological; Neoplasm Proteins; Neoplasms, Experimental; Pigmentation; Plasminogen Activators; RNA, Neoplasm; Virus Replication | 1976 |
Bromodeoxyuridine mutagenesis and deoxyribonucleotide pool imbalance in mammalian cells.
Topics: Animals; Base Composition; Bromodeoxyuridine; Cell Line; Cricetinae; Cytarabine; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; Deoxyribonucleotides; DNA; Drug Resistance; Fluorouracil; Hydroxyurea; Melanoma; Mutation; Ribonucleotide Reductases; Sister Chromatid Exchange; Thymidine | 1985 |
[Biochemistry of cell differentiation--introduction].
Topics: Acetylcholinesterase; Bromodeoxyuridine; Catechol Oxidase; Cell Differentiation; Cells, Cultured; Cholinesterases; Melanins; Melanocytes; Melanoma; Neuroblastoma; Retina; Tyrosine; Tyrosine 3-Monooxygenase | 1972 |
1 trial(s) available for bromodeoxyuridine and Malignant Melanoma
Article | Year |
---|---|
Proliferation rates in human malignant melanoma: relationship to clinicopathological features and outcome.
Topics: Aged; Bromodeoxyuridine; Cell Division; Disease-Free Survival; DNA, Neoplasm; Female; Humans; Male; Melanoma; Middle Aged; Mitosis; Prognosis; S Phase; Skin Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
104 other study(ies) available for bromodeoxyuridine and Malignant Melanoma
Article | Year |
---|---|
In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Humans; Melanocytes; Melanoma; Necrosis; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt | 2023 |
Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells.
Topics: Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Desmoglein 2; Electric Impedance; Gene Expression Profiling; Gene Expression Regulation; Humans; Immunoblotting; Immunohistochemistry; Melanoma; Microscopy, Fluorescence; Radioimmunoassay; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Secretogranin II | 2014 |
Inosine strongly enhances proliferation of human C32 melanoma cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways.
Topics: Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Humans; Inosine; Melanoma; Melanoma, Cutaneous Malignant; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Signal Transduction; Skin Neoplasms; Tetrazolium Salts; Thiazoles | 2015 |
Enhanced radiosensitization by the cationic liposome-encapsulated thymidine analogue BrdU through the increased intracellular BrdU-uptake on human melanoma as compared to anionic or nonionic liposomal or free BrdU.
Topics: Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cations; Cell Line, Tumor; Diffusion; Humans; Liposomes; Melanoma; Metabolic Clearance Rate; Nanocapsules; Radiation Tolerance; Radiation-Sensitizing Agents; Treatment Outcome | 2014 |
Sensitization to radiation-induced DNA damage accelerates loss of bcl-2 and increases apoptosis and autophagy.
Topics: Apoptosis; Autophagy; Bromodeoxyuridine; Cell Line, Tumor; Cyclin A; Cyclin-Dependent Kinase 2; DNA Damage; Humans; Melanoma; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; Skin Neoplasms; Ultraviolet Rays; Vacuoles | 2008 |
Kauren-19-oic acid induces DNA damage followed by apoptosis in human leukemia cells.
Topics: Acridine Orange; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Comet Assay; Diterpenes; DNA Damage; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ethidium; Fluorescent Dyes; Glioblastoma; HL-60 Cells; Humans; Inhibitory Concentration 50; Intercalating Agents; K562 Cells; Leukemia; Melanoma; Molecular Structure; Necrosis | 2009 |
Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice.
Topics: Animal Structures; Animals; Area Under Curve; Benzimidazoles; Bromodeoxyuridine; Cell Death; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Humans; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Tissue Distribution; Xenograft Model Antitumor Assays | 2011 |
Cryptotanshinone has diverse effects on cell cycle events in melanoma cell lines with different metastatic capacity.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Female; Genes, ras; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phenanthrenes; Proto-Oncogene Proteins B-raf; Salvia miltiorrhiza | 2011 |
The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.
Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Drug Screening Assays, Antitumor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Protein alpha Subunits; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Indoles; Isoenzymes; Melanoma; Mitogen-Activated Protein Kinase Kinases; Molecular Sequence Data; Mutation; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Uveal Neoplasms | 2012 |
An automated image capture and quantitation approach to identify proteins affecting tumor cell proliferation.
Topics: Automation; Bromodeoxyuridine; Carcinoma; Cell Division; Enzyme-Linked Immunosorbent Assay; Fluorescence; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lung Neoplasms; Melanoma; Neoplasm Proteins; Neoplasms; Sensitivity and Specificity; Tumor Cells, Cultured | 2004 |
Inhibition of endogenous reverse transcriptase antagonizes human tumor growth.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Line, Tumor; Enzyme Inhibitors; Humans; Melanoma; Microscopy, Confocal; Reverse Transcriptase Polymerase Chain Reaction; RNA-Directed DNA Polymerase; RNA, Small Interfering | 2005 |
The structure and position of mouse centromeric heterochromatin in BrdU-labelled chromosomes and diplochromosomes stained by the pH 10.4 method.
Topics: Animals; Azure Stains; Bromodeoxyuridine; Cell Line; Heterochromatin; Hydrogen-Ion Concentration; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Staining and Labeling | 1982 |
The effects of 5-bromodeoxyuridine on cyclic AMP levels and cytoskeletal organization in malignant melanoma cells.
Topics: Animals; Bromodeoxyuridine; Colchicine; Cyclic AMP; Cytoskeleton; Melanocyte-Stimulating Hormones; Melanoma; Mice; Microscopy, Electron; Microtubules; Neoplasms, Experimental; Tubulin | 1980 |
Bromodeoxyuridine substitution in mammalian DNA can both stimulate and inhibit restriction cleavage.
Topics: Animals; Bromodeoxyuridine; Cell Line; Cricetinae; DNA; DNA Restriction Enzymes; Enzyme Activation; Melanoma; Mesocricetus; Neoplasms, Experimental | 1980 |
Sequence-specific responses of restriction endonucleases to bromodeoxyuridine substitution in mammalian DNA.
Topics: Animals; Base Sequence; Bromodeoxyuridine; Cell Line; Cricetinae; DNA; DNA Restriction Enzymes; Kinetics; Melanoma; Mesocricetus; Neoplasms, Experimental; Protein Binding; Substrate Specificity | 1983 |
A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.
Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Humans; Infusions, Parenteral; Male; Melanoma; Middle Aged; Neoplasms; Radiation-Sensitizing Agents; Sarcoma | 1984 |
Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Bromodeoxyuridine; Cell Line; Cell Separation; Chromosomes; Cricetinae; Crossing Over, Genetic; DNA; Flow Cytometry; Histocytochemistry; Humans; Immunoenzyme Techniques; Melanoma; Sister Chromatid Exchange; Skin | 1983 |
Identification of bromodeoxyuridine in malignant and normal cells following therapy: relationship to complications.
Topics: Bone Marrow; Breast Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Female; Humans; Melanoma; Neoplasms; Photosensitivity Disorders; Radiation-Sensitizing Agents; Skin | 1984 |
Relationship of a novel extracellular matrix glycoprotein to cell detachment in highly metastatic B16 melanoma: modulating effect of bromodeoxyuridine.
Topics: Animals; Bromodeoxyuridine; Cell Adhesion; Chlorides; Electrophoresis, Polyacrylamide Gel; Glucosamine; Glycoproteins; Melanoma; Mice; Molecular Weight; Neoplasm Metastasis; Tritium; Zinc; Zinc Compounds | 1984 |
Unequal forms of 140-110 kD glycoproteins in B16 melanoma cells with differing detachment properties and metastatic behavior: influence of bromodeoxyuridine.
Topics: Animals; Bromodeoxyuridine; Cell Aggregation; Cell Line; Culture Media; Electrophoresis, Polyacrylamide Gel; Glycoproteins; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Molecular Weight; Neoplasm Proteins; Precipitin Tests | 1984 |
Differential effects of 5-bromodeoxyuridine on B16 mouse melanoma cells.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line; Melanoma; Mice | 1982 |
The role of u.v. light in the control of melanogenesis.
Topics: Bromodeoxyuridine; Cell Transformation, Neoplastic; Cells, Cultured; DNA; Enzyme Induction; Furocoumarins; Humans; Melanins; Melanocytes; Melanoma; Models, Biological; Monophenol Monooxygenase; Ultraviolet Rays | 1980 |
Bromodeoxyuridine-induced molecular species conversion of sialic acids of gangliosides and the alteration of cellular phenotypic expression in B16 mouse melanoma cells.
Topics: Animals; Bromodeoxyuridine; Cell Adhesion; Cells, Cultured; Gangliosides; Melanoma; Mice; Monophenol Monooxygenase; Neoplasm Proteins; Neoplasms, Experimental; Phenotype; Sialic Acids | 1982 |
Histopathology and host response associated with reduced tumorigenicity of 5-bromodeoxyuridine--treated murine melanoma cells.
Topics: Animals; Autoradiography; Bromodeoxyuridine; Cell Count; Cell Line; Female; Killer Cells, Natural; Male; Melanoma; Mice; Mice, Inbred C57BL; Microscopy, Electron; Mitosis; Neoplasm Transplantation | 1983 |
Unusual SCD in cancer cells: a phenomenon related to decreased BrdU incorporation?
Topics: Bromodeoxyuridine; Cell Cycle; Cell Line; Chromosome Banding; Crossing Over, Genetic; Humans; Karyotyping; Melanoma; Sister Chromatid Exchange | 1983 |
Bromodeoxyuridine mutagenesis, ribonucleotide reductase activity, and deoxyribonucleotide pools in hydroxyurea-resistant mutants.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Line; Cell Nucleus; Cricetinae; Deoxyribonucleotides; Drug Resistance; Hydroxyurea; Kinetics; Melanoma; Mesocricetus; Mutation; Ribonucleotide Reductases | 1981 |
Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice.
Topics: Animals; Bromodeoxyuridine; Graft Rejection; Immunity; Immunization; Killer Cells, Natural; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Retroviridae; Sarcoma, Experimental | 1982 |
Studies on the enhanced interaction of halodeoxyuridine-substituted DNAs with H1 histones and other polypeptides.
Topics: Animals; Bromodeoxyuridine; Cell Line; Cricetinae; DNA, Neoplasm; Histones; Kinetics; Melanoma; Mesocricetus; Muramidase; Peptides; Protamines; Protein Binding; Structure-Activity Relationship | 1980 |
Analysis of sister-chromatid exchanges and tumorigenicity in cell hybrids.
Topics: Animals; Bromodeoxyuridine; Crossing Over, Genetic; Fibroblasts; Humans; Hybrid Cells; Lymphocytes; Melanoma; Mice; Neoplasms; Sister Chromatid Exchange | 1980 |
A stochastic model for dual label experiments: an analysis of the heterogeneity of S phase duration.
Topics: Biomarkers; Bromodeoxyuridine; Choroid Neoplasms; Humans; Idoxuridine; Melanoma; S Phase; Stochastic Processes | 1995 |
Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Humans; Immunohistochemistry; Melanoma; Middle Aged; Mitotic Index; Multivariate Analysis; Prognosis; Proliferating Cell Nuclear Antigen; Reproducibility of Results; Survival Analysis; Uveal Neoplasms | 1995 |
Anticancer drug sensitivity profiles of new and established melanoma cell lines.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Melanoma; Tumor Cells, Cultured | 1993 |
The effects of incorporation of bromodeoxyuridine into mammalian DNA on the migration patterns of DNA fragments subjected to pulsed-field gel electrophoresis after X irradiation or cutting with a restriction enzyme.
Topics: Animals; Bacterial Proteins; Base Sequence; Blotting, Southern; Bromodeoxyuridine; Cell Line; Cell Survival; CHO Cells; Cricetinae; Deoxyribonucleases, Type II Site-Specific; DNA; DNA Probes; DNA, Neoplasm; Electrophoresis, Agar Gel; Humans; Melanoma; Molecular Sequence Data; Tumor Cells, Cultured; X-Rays | 1994 |
Spontaneous and induced differentiation of human melanoma cells.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Gene Expression; Genes, myc; Humans; In Vitro Techniques; Leucyl Aminopeptidase; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; RNA, Messenger; RNA, Neoplasm; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |
Heterogeneity of bromodeoxyuridine sensitivity of cultured cells from melanoma metastases.
Topics: Bisbenzimidazole; Bromodeoxyuridine; Cell Division; Ethidium; Flow Cytometry; G2 Phase; Genetic Heterogeneity; Humans; Melanoma; Monophenol Monooxygenase; Ploidies; Sensitivity and Specificity; Tumor Cells, Cultured | 1995 |
Radiation induced G1-block and p53 status in six human cell lines.
Topics: Antimetabolites; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Transformed; Culture Media, Serum-Free; DNA Damage; DNA, Neoplasm; Fibroblasts; G1 Phase; Humans; Male; Melanoma; Middle Aged; Mutation; Radiotherapy Dosage; Resting Phase, Cell Cycle; S Phase; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
p53 gene and cell cycling in uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Base Sequence; Bromodeoxyuridine; Cell Cycle; DNA Mutational Analysis; DNA Primers; DNA, Neoplasm; Female; Follow-Up Studies; Genes, p53; Humans; Immunoenzyme Techniques; Male; Melanoma; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Tumor Suppressor Protein p53; Uveal Neoplasms | 1996 |
Establishment and characterization of primary and metastatic uveal melanoma cell lines.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Bromodeoxyuridine; Cell Division; Cell Line; Culture Techniques; Female; Humans; Immunohistochemistry; Karyotyping; Kinetics; Male; Melanoma; Microscopy, Electron; Middle Aged; Tumor Cells, Cultured; Uveal Neoplasms | 1996 |
p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells.
Topics: Antimetabolites, Antineoplastic; Blood Proteins; Blotting, Western; Bromodeoxyuridine; CDC2-CDC28 Kinases; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Humans; Melanoma; Proliferating Cell Nuclear Antigen; Protein Serine-Threonine Kinases; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1996 |
Foetal human melanocytes: in situ detection, in vitro culture and differentiation characteristics at 6-11 weeks EGA.
Topics: Biomarkers, Tumor; Bromodeoxyuridine; Cell Differentiation; Cells, Cultured; Gestational Age; Humans; Melanocytes; Melanoma | 1996 |
PCR-mediated differential display and cloning of a melanocyte gene decreased in malignant melanoma and up-regulated with sensitization to DNA damage.
Topics: Base Sequence; Bromodeoxyuridine; Cell Differentiation; Cloning, Molecular; DNA Damage; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Melanocytes; Melanoma; Molecular Sequence Data; Polymerase Chain Reaction; Radiation-Sensitizing Agents; Resting Phase, Cell Cycle; RNA, Messenger; RNA, Neoplasm; Sequence Analysis, DNA; Tumor Cells, Cultured; Tyrosine; Ultraviolet Rays | 1996 |
Sensitization to DNA damage by okadaic acid or bromodeoxyuridine involves unequal effects on melanoma cell adhesion and differentiation.
Topics: Animals; Antimetabolites, Antineoplastic; Arsenicals; Bromodeoxyuridine; Cell Adhesion; Cell Differentiation; Cycloheximide; DNA Damage; DNA Fragmentation; Enzyme Inhibitors; Melanoma; Mice; Okadaic Acid; Phosphoprotein Phosphatases; Pigmentation; Protein Synthesis Inhibitors; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Ultraviolet Rays | 1997 |
Melatonin inhibits growth of cultured human uveal melanoma cells.
Topics: Bromodeoxyuridine; Cell Division; Humans; Liver Neoplasms; Melanoma; Melatonin; Tumor Cells, Cultured | 1997 |
Bromodeoxyuridine-induced expression of endothelin A in A375 human melanoma cells.
Topics: Animals; Bromodeoxyuridine; Calcium; Cell Differentiation; Endothelin-1; Gene Expression; Humans; Melanocytes; Melanoma; Mice; Mice, Nude; Models, Biological; Phenotype; Receptor, Endothelin A; Receptors, Endothelin; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1997 |
Cell cycling and prognosis in uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Cell Cycle; Eosine Yellowish-(YS); Hematoxylin; Humans; Melanoma; Middle Aged; Mitotic Index; Multivariate Analysis; Neoplasm Metastasis; Prognosis; Regression Analysis; Survival Analysis; Time Factors; Uveal Neoplasms | 1995 |
Proliferative potential of canine oral epulides and malignant neoplasms assessed by bromodeoxyuridine labeling.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Dog Diseases; Dogs; Female; Fibrosarcoma; Gingival Diseases; Gingival Neoplasms; Male; Melanoma; Mitotic Index; Mouth Neoplasms | 1999 |
Human melanoma cell line UV responses show independency of p53 function.
Topics: Blotting, Northern; Bromodeoxyuridine; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; GADD45 Proteins; Gene Expression; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; Melanoma; Mutagenesis; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ultraviolet Rays; Up-Regulation | 1999 |
Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine.
Topics: Adult; Aged; Bromine Radioisotopes; Bromodeoxyuridine; Cell Division; Female; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Tomography, Emission-Computed | 1999 |
G2-phase delays after irradiation and/or heat treatment as assessed by two-parameter flow cytometry.
Topics: Bromodeoxyuridine; Caffeine; Cell Cycle; Flow Cytometry; G2 Phase; Humans; Hyperthermia, Induced; Melanoma; Mitosis; S Phase; Tumor Cells, Cultured | 2001 |
Deoxycytidine reverses the suppression of pigmentation caused by 5-BrdUrd without changing the distribution of 5-BrdUrd in DNA.
Topics: Animals; Bromodeoxyuridine; Cell Line; Cricetinae; Deoxycytidine; DNA Replication; DNA, Neoplasm; Kinetics; Melanoma; Monophenol Monooxygenase; Nucleic Acid Renaturation; Pigments, Biological | 1979 |
Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Transformation, Neoplastic; Clone Cells; Enzyme Repression; Fibrinolysin; Fibrinolysis; Iodine Radioisotopes; Melanoma; Mice; Neoplasms, Experimental; Plasminogen | 1975 |
Requirement of bromodeoxyuridine for the maintenance of "transformed" characteristics in bromodeoxyuridine dependent cells.
Topics: Agglutination Tests; Animals; Blood Proteins; Bromodeoxyuridine; Cattle; Cell Line; Cell Transformation, Neoplastic; Concanavalin A; Contact Inhibition; Cricetinae; Culture Media; Cyclic AMP; DNA, Neoplasm; Female; Lectins; Melanoma; Mutation; Neoplasm Transplantation; Plant Lectins; Triticum | 1975 |
About the influence of halogenated pyrimidines on the in vivo-oncogenesis.
Topics: Animals; Bromodeoxyuridine; Cricetinae; Female; Fibrosarcoma; Friend murine leukemia virus; Idoxuridine; Leukemia, Experimental; Melanoma; Methylcholanthrene; Mice; Neoplasms, Experimental; Retroviridae; Sarcoma, Experimental | 1977 |
Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Fusion; Clone Cells; Dactinomycin; Melanoma; Mice; Mitomycins; Neoplasms, Experimental; Plasminogen Activators; Retroviridae | 1978 |
Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response.
Topics: Animals; Antilymphocyte Serum; Bromodeoxyuridine; Cell Fusion; Cell Line; Immunosuppression Therapy; Melanoma; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Plasminogen Activators; T-Lymphocytes | 1978 |
Proteins of BrdU-dependent hamster cell lines as characterized by two-dimensional gel electrophoresis.
Topics: Animals; Bromodeoxyuridine; Cell Line; Cricetinae; Electrophoresis, Polyacrylamide Gel; Kidney; Melanoma; Mesocricetus; Neoplasms, Experimental; Protein Biosynthesis | 1979 |
Virus-like particles induced by bromodeoxyuridine in melanoma and neuroblastoma of Xiphophorus.
Topics: Animals; Bromodeoxyuridine; Fish Diseases; Fishes; Inclusion Bodies, Viral; Melanoma; Microscopy, Electron; Neuroblastoma | 1979 |
Bromodeoxyuridine mutagenesis in mammalian cells is stimulated by purine deoxyribonucleosides.
Topics: Animals; Base Sequence; Bromodeoxyuridine; Cricetinae; DNA; Dose-Response Relationship, Drug; Melanoma; Mesocricetus; Mutagens; Neoplasms, Experimental; Purine Nucleosides; Stimulation, Chemical | 1979 |
Resistance to bromodeoxyuridine mutagenesis and toxicity in mammalian cells selected for resistance to hydroxyurea.
Topics: Animals; Bromodeoxyuridine; Cell Line; Cricetinae; DNA; Drug Resistance; Hydroxyurea; Melanoma; Mesocricetus; Neoplasms, Experimental; Phenotype | 1979 |
Novel phenotypes arising from selection of hamster melanoma cells for resistance to BUdR.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; Clone Cells; Cricetinae; DNA, Neoplasm; Drug Resistance; Melanoma; Phenotype; Pigmentation; Thymidine; Thymidine Kinase | 1977 |
Bromodeoxyuridine treatment of melanoma cells decreases rubidium transport.
Topics: Animals; Biological Transport, Active; Bromodeoxyuridine; Culture Techniques; Melanoma; Mice; Ouabain; Radioisotopes; Rubidium | 1978 |
Reversible suppression of malignancy and differentiation of melanoma cells.
Topics: Bromodeoxyuridine; Cell Differentiation; Cell Division; Cells, Cultured; Immunization; Melanoma; Neoplasms, Experimental; Pigmentation; Plasminogen Activators | 1977 |
Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisions.
Topics: Animals; Bromodeoxyuridine; Catechol Oxidase; Cell Differentiation; Cell Division; Cell Survival; Clone Cells; DNA, Neoplasm; Melanoma; Mice; Neoplasm Proteins; Neoplasms, Experimental; Pigmentation; RNA, Neoplasm | 1975 |
Cell surface changes caused by growth of B16 melanoma cells in bromodeoxyuridine.
Topics: Bromodeoxyuridine; Cell Adhesion; Cell Line; Cell Membrane; Dextrans; Electrophoresis; Melanoma; Neoplasms, Experimental; Polyethylene Glycols; Solubility; Surface Properties | 1977 |
Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cells, Cultured; Deoxyuridine; DNA, Neoplasm; Kinetics; Melanins; Melanoma; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Thymidine; Transplantation, Homologous | 1977 |
The effect of 5-bromodeoxyuridine on messenger RNA production in cultured cells.
Topics: Animals; Bromodeoxyuridine; Cells, Cultured; DNA, Neoplasm; Kinetics; Melanoma; Mice; Nucleic Acid Hybridization; Poly A; RNA, Messenger | 1976 |
Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes.
Topics: Adult; Aged; Animals; Bromodeoxyuridine; Cell Division; Cell Line; Chromosome Aberrations; Chromosomes, Human, 6-12 and X; Female; Glucosephosphate Dehydrogenase; Humans; Isoenzymes; Karyotyping; Male; Melanins; Melanocytes; Melanoma; Mice; Mice, Nude; Middle Aged; Neoplasm Metastasis; Neoplasms, Experimental; Phenotype; Phosphoglucomutase; Time Factors | 1976 |
Inhibition of biological effects of bromodeoxyuridine by deoxycytidine: correlation with decreased incorporation of bromodeoxyuridine into DNA.
Topics: Animals; Bromodeoxyuridine; Cell Line; Contact Inhibition; Cricetinae; Culture Media; Deoxycytidine; DNA, Neoplasm; In Vitro Techniques; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental; Pigmentation | 1976 |
The production of acidic polysaccharides by 5-bromodeoxyuridine-treated B16 mouse melanoma cells.
Topics: Animals; Bromodeoxyuridine; Cells, Cultured; Chondroitin; Depression, Chemical; DNA; Glucosamine; Glycopeptides; Heparitin Sulfate; Hyaluronic Acid; Melanoma; Mice; Neoplasms, Experimental; Polysaccharides; Proteoglycans; Sialic Acids; Thymidine | 1975 |
Cell kinetics of human solid tumours.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; Colorectal Neoplasms; Flow Cytometry; Humans; Melanoma; Prognosis; Prospective Studies; Skin Neoplasms | 1992 |
Cytotoxicity of a selected series of substituted phenols towards cultured melanoma cells.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Survival; Flow Cytometry; Humans; L-Lactate Dehydrogenase; Melanoma; Phenols; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Modulation of ganglioside expression in human melanoma cell lines; increased resistance to chemo- and radiation treatment.
Topics: Antineoplastic Agents; Bleomycin; Bromodeoxyuridine; Cell Survival; Chromatography, Thin Layer; Cisplatin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Resistance; Gangliosides; Humans; Melanoma; Membrane Lipids; Mercaptopurine; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine | 1992 |
Bromodeoxyuridine hypersensitivity of metastatic melanoma cells.
Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Oxygen | 1992 |
Effects of retinoic acid and bromodeoxyuridine on human melanoma-associated antigen expression in small cell lung carcinoma cells.
Topics: Antigens, Neoplasm; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Adhesion; Flow Cytometry; Humans; Lung Neoplasms; Melanoma; Melanoma-Specific Antigens; Neoplasm Proteins; Precipitin Tests; Tretinoin; Tumor Cells, Cultured | 1991 |
Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Bromodeoxyuridine; Cell Differentiation; Cyclic AMP; Flow Cytometry; Humans; Immunohistochemistry; Melanoma; Mice; Neuroblastoma; Precipitin Tests; Tretinoin | 1991 |
Ki-67 and bromodeoxyuridine labeling of human choroidal melanoma cells.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Bromodeoxyuridine; Choroid Neoplasms; Fluorescent Antibody Technique; Humans; Ki-67 Antigen; Melanoma; Nuclear Proteins; Tumor Cells, Cultured | 1991 |
Effect of thymidine analogs on tyrosinase activity and mRNA accumulation in mouse melanoma cells.
Topics: Animals; Bromodeoxyuridine; Catechol Oxidase; Cell Line; Cell Transformation, Neoplastic; Floxuridine; Idoxuridine; Melanoma; Mice; Monophenol Monooxygenase; RNA, Messenger; Thymidine | 1990 |
Analysis of radiation failure after uveal melanoma brachytherapy.
Topics: Aged; Brachytherapy; Bromodeoxyuridine; Choroid Neoplasms; DNA, Neoplasm; Eye Enucleation; Female; Humans; Iodine Radioisotopes; Male; Melanoma; Middle Aged; Mitosis; Neoplasm Recurrence, Local; Uveal Neoplasms | 1989 |
Bromodeoxyuridine uptake in the assessment of hyperthermic therapy for intraocular tumor.
Topics: Animals; Biopsy, Needle; Bromodeoxyuridine; DNA; Eye Neoplasms; Hyperthermia, Induced; Male; Melanoma; Rabbits | 1989 |
DNA cell cycle studies in uveal melanoma.
Topics: Aged; Bromodeoxyuridine; Cell Cycle; Cell Separation; Cells, Cultured; Choroid Neoplasms; Ciliary Body; DNA; Flow Cytometry; Humans; Melanoma; Middle Aged; Uveal Neoplasms | 1988 |
Alteration of the Cloudman melanoma cell cycle by prostaglandins E1 and E2 determined by using a 5-bromo-2'-deoxyuridine method of DNA analysis.
Topics: Alprostadil; Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Line; Dinoprost; Dinoprostone; DNA; Melanoma; Mice; Microscopy, Electron; Monophenol Monooxygenase; Prostaglandins E; Prostaglandins F | 1988 |
Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Cell Line; DNA, Neoplasm; Flow Cytometry; Fluorescent Dyes; Melanoma; Mice; Phenanthridines; Propidium; Prostaglandins E; Tumor Cells, Cultured | 1988 |
Immunohistochemical detection of proliferating cells in vivo.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Bromodeoxyuridine; Cell Division; DNA; Flow Cytometry; Histocytochemistry; Immunoenzyme Techniques; Interphase; Intestinal Mucosa; Intestines; Melanoma; Mice; Mice, Inbred C57BL | 1987 |
Reversion analysis of mutations induced by 5-bromodeoxyuridine mutagenesis in mammalian cells.
Topics: Animals; Bromodeoxyuridine; Cell Line; Cricetinae; Deoxyribonucleotides; DNA Replication; Ethyl Methanesulfonate; Hypoxanthine Phosphoribosyltransferase; Melanoma; Mesocricetus; Methylnitronitrosoguanidine; Mutation | 1985 |
Extent of morphological differentiation of human melanoma cells reflected by HLA-DR antigen profiles.
Topics: Bromodeoxyuridine; Cell Line; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Killer Cells, Natural; Lymphocyte Activation; Melanoma; Theophylline | 1985 |
RNA-directed DNA-polymerase activity in Greene hamster melanoma.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Avian Leukosis Virus; Bromodeoxyuridine; Cell Line; Cricetinae; Cytosine Nucleotides; DNA; Enzyme Activation; Guanine Nucleotides; Kinetics; Magnesium; Manganese; Melanoma; Neoplasms, Experimental; Oncogenic Viruses; Polynucleotides; RNA Viruses; RNA-Directed DNA Polymerase; Stimulation, Chemical; Templates, Genetic; Thymine Nucleotides; Thymus Gland; Tritium | 1973 |
S-tropic murine type-C viruses: frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Animals; Bromodeoxyuridine; Cell Line; Clone Cells; Connective Tissue; Female; Gammaretrovirus; Goats; Leukemia; Liver; Melanoma; Mice; Mice, Inbred Strains; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Radioimmunoassay; Rauscher Virus; Retroviridae; RNA-Directed DNA Polymerase; Sarcoma 180; Spleen; Tritium; Virus Cultivation | 1974 |
The ultrastructure of melanoma cells treated with 5-bromodeoxyuridine.
Topics: Animals; Bromodeoxyuridine; Catechol Oxidase; Cell Line; Culture Media; Culture Techniques; Histocytochemistry; Inclusion Bodies, Viral; Melanocytes; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Organoids; Pigmentation; Transplantation, Homologous | 1974 |
[Treatment of malignant brain tumors by BAR therapy].
Topics: Adolescent; Adult; Arteries; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Ependymoma; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Parenteral; Male; Melanoma; Meningioma; Middle Aged; Neoplasm Metastasis; Oligodendroglioma; Papilloma | 1968 |
Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine.
Topics: Animals; Antigens, Viral; Bromodeoxyuridine; Cell Line; Clone Cells; Fluorescent Antibody Technique; Leukemia Virus, Murine; Melanoma; Mice; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental | 1972 |
Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.
Topics: Animals; Animals, Newborn; Antigens, Neoplasm; Antigens, Viral; Antilymphocyte Serum; Bromodeoxyuridine; Cell Division; Cell Membrane; Clone Cells; Cytotoxicity Tests, Immunologic; Histocompatibility Antigens; Immunosuppression Therapy; Melanoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Retroviridae; Transplantation, Homologous; Virus Replication | 1974 |
Bromodeoxyuridine dependence--a new mutation in mammalian cells.
Topics: Aminopterin; Animals; Bromodeoxyuridine; Cell Division; Cell Line; Centrifugation, Density Gradient; Clone Cells; Cricetinae; Culture Media; DNA, Neoplasm; Hypoxanthines; Melanoma; Molecular Weight; Mutation; Neoplasms, Experimental; Phosphates; Phosphorus Isotopes; Radiation Effects; Thymidine; Tritium; Ultraviolet Rays | 1973 |
Total substitution of bromodeoxyuridine for thymidine in the DNA of a bromodeoxyuridine-dependent cell line.
Topics: Aminopterin; Animals; Autoradiography; Bromodeoxyuridine; Cell Line; Chemical Phenomena; Chemistry; Cricetinae; DNA, Neoplasm; Electrophoresis; Melanoma; Methods; Syria; Thymidine | 1974 |
Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; Cell Transformation, Neoplastic; Contact Inhibition; Cricetinae; DNA, Neoplasm; Melanoma | 1974 |
5-Bromodeoxyuridine-tolerant melanoma cells in vitro and in vivo.
Topics: Animals; Bromodeoxyuridine; Carbon Radioisotopes; Cell Line; Centrifugation, Density Gradient; Deoxyadenosines; DNA, Neoplasm; Drug Resistance; Male; Melanoma; Mice; Mice, Inbred C57BL; Molecular Weight; Mutation; Neoplasm Transplantation; Neoplasms, Experimental; Phenotype; Pigmentation; Tritium | 1973 |
Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation.
Topics: Animals; Bromodeoxyuridine; Catechol Oxidase; Cell Line; Cell Nucleus; Clone Cells; Electrophoresis, Polyacrylamide Gel; Golgi Apparatus; Histocytochemistry; Melanocytes; Melanoma; Mice; Microscopy; Microscopy, Electron; Pigmentation; Subcellular Fractions; Time Factors | 1973 |
Effect of 5-bromodeoxyuridine (BUdR) on experimental metastasis.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Clone Cells; Dose-Response Relationship, Drug; Idoxuridine; Lung Neoplasms; Melanoma; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Thymidine; Time Factors | 1973 |
Ultrastructural effects of thymidine analogs in melanosomes and virus activation in cloned hamster melanoma cells in culture.
Topics: Animals; Bromodeoxyuridine; Clone Cells; Golgi Apparatus; Idoxuridine; Melanins; Melanocytes; Melanoma; Mice; Oncogenic Viruses; Organoids; Pigmentation; RNA Viruses; Virus Replication | 1973 |
8-Azaguanine-resistant melanoma cells in vitro and in vivo.
Topics: Aminopterin; Animals; Azaguanine; Bromodeoxyuridine; Cell Division; Cell Fusion; Cell Line; Drug Resistance; Glycine; Guanine; Hybrid Cells; Hypoxanthines; Karyotyping; Melanoma; Mice; Mice, Inbred C57BL; Molecular Biology; Neoplasms, Experimental; Pentosyltransferases; Thymidine; Thymidine Kinase | 1974 |
Inhibition of melanogenesis with 5-bromodeoxyuridine treatment in a single period of DNA synthesis.
Topics: Bromodeoxyuridine; Cell Differentiation; Cell Division; Cells, Cultured; Depression, Chemical; DNA; Melanins; Melanoma; Thymidine; Tritium | 1974 |
Altered amino acid concentrations accompanying suppression of malignancy of mouse melanoma cells by 5-bromodeoxyuridine.
Topics: Alanine; Amino Acids; Animals; Asparagine; Bromodeoxyuridine; Cells, Cultured; Glutamates; Glutamine; Glycine; Lysine; Melanoma; Methionine; Mice; Neoplasm Proteins; Ornithine; Phenylalanine; Pigmentation; Proline; Serine; Threonine; Valine | 1974 |
Suppression of malignancy and differentiation in melanotic melanoma cells.
Topics: Animals; Bromodeoxyuridine; Clone Cells; Culture Techniques; Melanoma; Mice; Microscopy, Phase-Contrast; Mitosis; Neoplasms, Experimental; Pigments, Biological; Thymidine; Tritium | 1970 |
An amelanotic variant of B16 malignant melanoma.
Topics: Animals; Bromodeoxyuridine; Cell Line; Culture Media; Male; Melanins; Melanoma; Methods; Mice; Mice, Inbred Strains; Mutation; Neoplasm Transplantation; Neoplasms, Experimental; Time Factors | 1972 |
A "loop" model for integration of donor DNA into host DNA of eukaryote cells.
Topics: Alleles; Animals; Bromodeoxyuridine; Cell Differentiation; Cell Nucleus; Cell Transformation, Neoplastic; Centrifugation, Density Gradient; Chromosomes; Cricetinae; DNA; DNA Replication; DNA, Neoplasm; In Vitro Techniques; Leukemia L1210; Melanoma; Mice; Models, Chemical; Nucleic Acid Denaturation; Ribonucleases; Spermine; Transformation, Genetic; Tritium | 1972 |